Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gen Suzuki

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Molecular and Clinical Oncology|June 8, 2017
Clinical outcome of patients treated with re-irradiation for spine or pelvic bone metastasis: A multi-institutional analysis of 98 patientsGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Japanese Journal of Radiology|May 5, 2009
Comparison of cisplatin and 5-fluorouracil chemotherapy protocols combined with concurrent radiotherapy for esophageal cancerToru Sakayauchi, Kenji Nemoto, Chikashi Ishioka, et al.
Journal of Radiation Research|April 9, 2020
High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacerKoji Masui, Hideya Yamazaki, Gen Suzuki, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapyKatsumasa Nakamura, Yoshiyuki Shioyama, Mitsuhiko Kawashima, et al.
Radiation Oncology (London, England)|November 19, 2022
Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomesGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Anticancer Research|June 26, 2024
Optimizing Therapeutic Approaches in Superficial Esophageal Cancer: Reduced-volume Radiotherapy and Dose-dense Chemotherapy After Endoscopic ResectionGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Scientific Reports|April 5, 2024
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapyHideya Yamazaki, Gen Suzuki, Koji Masui, et al.
In Vivo (Athens, Greece)|September 3, 2020
Comparison of Three Fractionation Schedules in Radiotherapy for Early Glottic Squamous Cell CarcinomaGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Neuro-Oncology|June 19, 2008
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004Yuta Shibamoto, Hiroyuki Ogino, Gen Suzuki, et al.
Cancers|June 24, 2022
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10Hideya Yamazaki, Gen Suzuki, Koji Masui, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Molecular and Clinical Oncology|June 8, 2017
Clinical outcome of patients treated with re-irradiation for spine or pelvic bone metastasis: A multi-institutional analysis of 98 patientsGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Japanese Journal of Radiology|May 5, 2009
Comparison of cisplatin and 5-fluorouracil chemotherapy protocols combined with concurrent radiotherapy for esophageal cancerToru Sakayauchi, Kenji Nemoto, Chikashi Ishioka, et al.
Journal of Radiation Research|April 9, 2020
High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacerKoji Masui, Hideya Yamazaki, Gen Suzuki, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapyKatsumasa Nakamura, Yoshiyuki Shioyama, Mitsuhiko Kawashima, et al.
Radiation Oncology (London, England)|November 19, 2022
Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomesGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Anticancer Research|June 26, 2024
Optimizing Therapeutic Approaches in Superficial Esophageal Cancer: Reduced-volume Radiotherapy and Dose-dense Chemotherapy After Endoscopic ResectionGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Scientific Reports|April 5, 2024
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapyHideya Yamazaki, Gen Suzuki, Koji Masui, et al.
In Vivo (Athens, Greece)|September 3, 2020
Comparison of Three Fractionation Schedules in Radiotherapy for Early Glottic Squamous Cell CarcinomaGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Neuro-Oncology|June 19, 2008
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004Yuta Shibamoto, Hiroyuki Ogino, Gen Suzuki, et al.
Cancers|June 24, 2022
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10Hideya Yamazaki, Gen Suzuki, Koji Masui, et al.
Pageof 24